#United States #Orlando #Specialty Pharmacy #Biosimilars #AcariaHealth

AcariaHealth's Commitment to Biosimilars Education

In October 2025, AcariaHealth, a recognized leader in specialty pharmacy services and a subsidiary of Centene Corporation, conducted three significant national educational events aimed at transforming the approach to biosimilars in the U.S. healthcare system. These sessions, in collaboration with notable organizations like the National Association of Specialty Pharmacy (NASP) and Reuters Events, focused on delivering real-world insights to healthcare professionals about biosimilar utilization. The primary goal was to enhance patient access and improve treatment outcomes, addressing some of the prevalent barriers in the current medical landscape.

Insights from the Educational Events

The series kicked off with a Lunch and Learn session organized by NASP, titled "Biosimilars Unveiled: Strategies for Success in Specialty Pharmacy." The session was led by Kathleen Stenberg, PharmD, CSP, who is the Lead Specialty Pharmacist at AcariaHealth. This presentation aims to equip attendees with foundational knowledge about biosimilars, answering routine queries from both providers and patients, and unpacking strategies to navigate the complexities of substitution and workflow within the specialty pharmacy environment.

In addition to the NASP event, a panel discussion hosted by Reuters Events titled "Biosimilars in U.S. Healthcare: Adoption, Opportunities, and Outcomes" brought together industry leaders who discussed the latest trends in biosimilar usage, regulatory considerations, and the obstacles patients face in accessing these therapies. Dr. Stenberg played a crucial role here as well, sharing her insights on how specialty pharmacies can better prepare for the integration of biosimilars into patient care protocols.

The finale was an engaging webinar hosted by AcariaHealth itself, titled "Biosimilars in Practice: Maintaining Access and Prioritizing Patient Care." This session included multiple speakers like Alysha Robinson and Robin Waida, who provided both practical and theoretical frameworks about integrating biosimilars successfully. They emphasized addressing the common hesitations that both providers and patients often face concerning biosimilars.

Key Takeaways

Throughout these events, several key insights emerged:

• - Regulatory Understanding: There is an evolving landscape concerning biosimilars that healthcare providers must stay informed about to facilitate adoption effectively.
• - Communication is Key: Developing clear communication strategies can significantly reduce hesitations among providers and patients, thus facilitating easier integration of biosimilars into treatment plans.
• - System-Level Considerations: There’s a need to examine and optimize systems not just for biosimilar integration but also concerning payer dynamics and substitution regulations, ensuring that workflows adapt to new protocols efficiently.

A Commitment to Education

Jessica Ciccolella-Kahl, the CEO of AcariaHealth, highlighted the company's ongoing commitment to educating healthcare professionals. "Our goal is to empower providers with the necessary knowledge and resources to integrate biosimilars into their practice confidently. Education is a crucial step in ensuring that patients can access safe, effective, and affordable therapies," she remarked. The recordings from these sessions are now available on-demand, allowing an even broader audience of healthcare professionals to benefit from the insights.

AcariaHealth stands as a national specialty pharmacy dedicated to providing personalized care to patients grappling with complex health conditions. Backed by Centene Corporation, they harness the resources of one of the largest Medicaid managed care organizations, ensuring transformative outcomes for patients across the nation.

For those looking to delve more into biosimilars or explore other services from AcariaHealth, resources are available at AcariaHealth.com. For continuous updates and news, follow their journey on LinkedIn where they engage with a community dedicated to improving patient care in specialty pharmacy.